ACC.26 - Dr Anuradha Lala-Trindade (Mount Sinai, New York, NY, US) provides her expert analysis of the most impactful late-breaking clinical trials presented at ACC.26, highlighting studies with the potential to influence clinical practice and shape future cardiovascular care.  

Key Late-Breaking Trials Discussed
0:16 – STEMI-DTU: Primary Left Ventricular Unloading in Anterior ST-Segment Elevation Myocardial Infarction (STEMI) Without Cardiogenic Shock – Results from the STEMI-Door to Unload Randomized Clinical Trial.
2:24 – GOFRESH: DASH-Patterned Groceries to Reduce Blood Pressure Among Adults With Treated Hypertension – Results from the GoFreshRx Randomized Clinical Trial.
4:05 – HI-PEITHO: Ultrasound-facilitated Catheter-directed Thrombolysis vs Anticoagulation Alone for Acute Intermediate-high-risk Pulmonary Embolism – Primary Results from the HI-PEITHO Randomized Clinical Trial.

From acute MI management to equitable heart failure prevention, and innovation in PE therapy, these are Dr. Lala’s top insights from this year’s ACC Annual Scientific Session.

For more expert insights and late-breaking science from ACC 2026, visit the Late-breaking Science Video Collection.

Editor:Jordan Rance, Mirjam Boros  
Videographer:Mike Knight

Support: This is an independent educational video produced by Radcliffe Cardiology.